DE69110133D1 - Herstellung und charakterisierung der liposomformulierungen des tumornekrosefaktors. - Google Patents

Herstellung und charakterisierung der liposomformulierungen des tumornekrosefaktors.

Info

Publication number
DE69110133D1
DE69110133D1 DE69110133T DE69110133T DE69110133D1 DE 69110133 D1 DE69110133 D1 DE 69110133D1 DE 69110133 T DE69110133 T DE 69110133T DE 69110133 T DE69110133 T DE 69110133T DE 69110133 D1 DE69110133 D1 DE 69110133D1
Authority
DE
Germany
Prior art keywords
tnf
modified
liposome
liposomes
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69110133T
Other languages
English (en)
Other versions
DE69110133T2 (de
Inventor
Mien-Chie Hung
Toshihiko Utsumi
Jim Klostergaard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Publication of DE69110133D1 publication Critical patent/DE69110133D1/de
Application granted granted Critical
Publication of DE69110133T2 publication Critical patent/DE69110133T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69110133T 1990-10-18 1991-10-16 Herstellung und charakterisierung der liposomformulierungen des tumornekrosefaktors. Expired - Fee Related DE69110133T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59981190A 1990-10-18 1990-10-18
PCT/US1991/007694 WO1992006995A1 (en) 1990-10-18 1991-10-16 Preparation and characterization of liposomal formulations of tumor necrosis factor

Publications (2)

Publication Number Publication Date
DE69110133D1 true DE69110133D1 (de) 1995-07-06
DE69110133T2 DE69110133T2 (de) 1996-02-15

Family

ID=24401193

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69110133T Expired - Fee Related DE69110133T2 (de) 1990-10-18 1991-10-16 Herstellung und charakterisierung der liposomformulierungen des tumornekrosefaktors.

Country Status (7)

Country Link
EP (1) EP0553281B1 (de)
JP (1) JPH06501702A (de)
AT (1) ATE123290T1 (de)
AU (1) AU9029591A (de)
CA (1) CA2091771A1 (de)
DE (1) DE69110133T2 (de)
WO (1) WO1992006995A1 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283046C (en) * 1986-05-29 1991-04-16 Nandini Katre Tumor necrosis factor formulation
DE3936777A1 (de) * 1989-11-04 1991-05-08 Basf Ag Quervernetzte tumor-nekrose-faktoren

Also Published As

Publication number Publication date
EP0553281A1 (de) 1993-08-04
JPH06501702A (ja) 1994-02-24
WO1992006995A1 (en) 1992-04-30
EP0553281B1 (de) 1995-05-31
DE69110133T2 (de) 1996-02-15
ATE123290T1 (de) 1995-06-15
CA2091771A1 (en) 1992-04-19
AU9029591A (en) 1992-05-20

Similar Documents

Publication Publication Date Title
ES2194114T3 (es) Formulaciones liposomicas de mitoxantrona.
FI103731B (fi) Uusia, tekijä VIII-aktiivisuutta omaavia proteiineja koodittava DNA-sekvenssi ja menetelmä näiden proteiinien valmistamiseksi
HK1007497A1 (en) Accumulations of amino acids and peptides into liposomes
RU94042240A (ru) Антагонисты рецепторов возбужденных аминокислот, способ получения, промежуточные соединения, фармацевтическая композиция
DK1151102T3 (da) Glycosylerede leptinpræparater og relaterede fremgangsmåder
FI20075338A (fi) gb350/220:n ei silmukoivia muutoksia
GR900100772A (el) Μέ?οδος για την παρασκευή φαρμακευτικών σκευασμάτων.
WO2001019852A8 (en) Methods of peptide preparation
DE69110133D1 (de) Herstellung und charakterisierung der liposomformulierungen des tumornekrosefaktors.
AU637404B2 (en) Chemically modified allergens and process for the preparation thereof
Li et al. Preparation and characterization of PEGylated adducts of recombinant human tumor necrosis factor-α from Escherichia coli
AU676464B2 (en) Proteolytic mixture containing escharase and method of isolating same
CA2104043A1 (en) Melanin formation-inhibitory protein, and its preparation and uses
JPH03109311A (ja) 洗浄用化粧料
ITMI912837A1 (it) Procedimento per preparare prodotti peptidici e/o proteinici arricchiti con amminoacidi legati in modo covalente
RU93052408A (ru) Ациламино-алкилиден-гидрокси-бис-фосфоновые кислоты, способ их получения, фармацевтическая композиция
RU94042815A (ru) Способ получения производных 5,6-фталилфенотиазина
AR010816A1 (es) Crema para borrar cicatrices (estrias) en los fibroplastos de la dermis profunda y proceso para la preparacion
TH39537EX (th) กรรมวิธีใหม่สำหรับเตรียมเพพไทด์ที่ถูกไลโอฟิไลซ์
AR010812A1 (es) Crema de belleza integral, nutriente, suavizante y quitamanchas solares y proceso para la preparacion
MX9700199A (es) Composiciones de cadena invariante utiles para tratar enfermedades autoinmunes.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee